5H-PYRROLO(3',4':5,6)(1,4)DITHIINO(2,3-C)-(1,2,5)THIADIAZOLE-5,7(6H)-DIONE, COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANTIMICROBIAL AND MARINE ANTIFOULING AGENTS

Abstract: Various 5H-pyrrolo(3',4':5,6)(1,4)dithiino-(2,3-C)(1,2,5)thiadiazole-5,7(6H)-diones corresponding to formula (I) wherein R represents -H, benzyl, phenethyl, a C1-C10 straight or branched chain alkyl radical, a C3-C10-cycloalkyl radical, a C1-C10 straight or branched chain alkoxy radical, a C3-C10-cycloalkoxy, an ester of the formula -CH2CH2O-C(O)-R<1>, wherein R<1> represents a C1-C6 straight or branched chain alkyl radical or a C3-C6 cycloalkyl radical or R represents phenyl substituted with from 0-5 halo, C1-C6 straight or branched chain alkyl, cyano, nitro groups, or an ester of the formula -OC(O)-R<1>, wherein R<1> represents a C1-C6 straight or branched chain alkyl radical or a C3-C6 cycloalkyl radical or an amide of the formula -C(O)-N(R<2>)x, wherein each R<2> independently represents a C1-C6 straight or branched chain alkyl radical or a C3-C6 cycloalkyl radical are disclosed. These compounds have been found to exhibit antimicrobial and marine antifouling activity in industrial and commercial applications and compositions containing these compounds are so employed.

Description: 5H-PYRROLO(3',4':5,6)(1 ,4)DITHIINO(2 > 3-C)-(1 ,2,5)THIADIAZOLE-5,7(6H)-DIONE, COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANTIMICROBIAL AND MARINE ANTIFOULING AGENTS The present invention is directed to certain 5H-pyrrolo(3',4'.5,6)(1 ,4)- 5 dιthιιno(2,3-C)-(1 ,2,5)thιadιazole-5,7(6H)-dιone, compositions containing these type of compounds and their use as antimicrobial and marine antifouhng agents. The present invention is directed to the antimicrobial and marine antifouhng uses of 5H-pyrrolo(3',4':5,6)(1 ,4)dιthιιno(2,3-C)-(1,2,5)thιadιazoie-5,7(6H)- dione corresponding to the formula wherein R represents -H, benzyl, phenethyl, a C,-C 0 straight or branched chain alkyl radical, a C 3 -C- 0 cycloalkyl radical, a C--C 10 straight or branched chain alkoxy radical, a C 3 -C. 0 -cycloalkoxy, an ester of the formula -CH 2 CH 2 O-C(O)-R\ wherein R' represents a C,-C o straight or branched chain alkyl radical or a C 3 -C 6 cycloalkyl radical or R 15 represents phenyl substituted with from 0-5 halo, C -C o straight or branched chain alkyl, cyano, nitro groups, or an ester of the formula -OC(O)-R', wherein R 1 represents a C.-C D straight or branched chain alkyl radical or a C 3 -C 6 cycloalkyl radical or an amrde of the formula -C(O)-N(R z ' < wherein each R ? independently represents a C.-C o straight or branched chain alkyl radical or a C^C.. cycloalkyl radical. 20 The present invention is further directed to a method 'or inhibiting microorganisms present in a microbial habitat which comprises contacting said microbial habitat with an antimicrobial composition comprising an inert diluent in admixture with an antimicrobially-effective amount of a compound corresponding to Formula I 25 The antimicrobial compositions of the present invention can also be employed to treat surfaces exposed to a marine environment in which marine organisms grow to prevent the growth of said marine organisms on said surfaces. The dione compounds corresponding to Formula I of the present invention can be prepared employing a preparative procedure such as set forth below. ■ ?0 In the following process schematic formulas, certain specific alkali metals, halo groups and specific solvents are set forth. These representations are only presented for convenience and are not to be considered as an indication that these specific representations are the only groups or materials which can be employed Preparation procedure: In the first step of this procedure, 3,4-dιchloro- 1 ,2,5-thιadιazole is reacted, with agitation and in a polar aprotic solvent, with an alkali metal sulfide to prepare the corresponding dialkali metal salt. Representative polar solvents which can be employed in the present process include water, acetone, dimethylformamide, dimethylsulfoxide, dimethylacetamide and N-methylpyrrolidone. The reactions are typically carried out at room temperature under a nitrogen atmosphere. The reactants may be added to the reaction mixture in any order of addition; conventionally they are added as a solution in the solvent used for the reaction. The reaction is allowed to continue over a period of from 10 minutes to 15 hours The reaction consumes the reactants in the ratio of one mole equivalent of the ha de reactant per mole of the alkali metal sulfide reactant To insure the completion of the reaction, an excess of the alkali metal sulfide reactant is normally employed. After the completion of the reaction, a stoichiometπc amount of an appropriately substituted dihalomaleimide is added to the reaction mixture (Step B) and the mixture is stirred at room temperature under a nitrogen atmosphere for a period of from 3 to 16 hours or more In most cases the product precipitates out from the reaction mixture, if not, methanol and/or water can be added to aid in precipitation The product is recovered by filtration, washed with water and/or methanol and air dried The reaction scheme is as follows STEP A STEP B In the present specification and claims, the term "alkali metal" is employed to designate sodium, potassium, lithium or cesium. In the present specification and claims, the term "halo" is employed to designate bromo, chloro, fluoro or iσdo Since the hereinabove and hereinafter set forth compound preparation procedures employ only standard chemistry practices and it is known that slightly different reactants can require slightly different reaction parameters from those for other reactants, it is to be understood that minor modifications to the reaction parameters set forth such as the use of an excess of one reactant, the use of a catalyst, the use of temperatures slightly higher than room temperature and/or high speed mixing and other such conventional changes are within the scope of the present invention. The structure identity of all compounds is confirmed by proton nuclear magnetic resonance spectroscopy ( H NMR), recorded at 300 MHz, carbon nuclear magnetic resonance spectroscopy ( ,3 C NMR) recorded at 75 MHz; infrared spectroscopy (IR) and mass spectrometry (MS) All of the reactions are conducted under a positive pressure of nitrogen The following examples illustrate the present invention and the manner by which it can be practiced but, as such, should not be construed as limitations upon the overall scope of the same EXAMPLE I. 5H-Pyrrolo(3',4'.5,6)(1 ,4)dιthιιno-(2,3-C)(1 ,2,5)thιadιazole-5,7(6H)-dιone A reaction mixture was prepared by slowly adding (3.7 grams (g), 0.024 mol) of 3,4-dιchloro-1 ,2,5-thιadιazole to a solution of 1 1.6 g (0.048 mol) of sodium sulfide monohydrate (Na 2 S 9 H 2 O) in 50 mL of water. The mixture was stirred for 2 hours at room temperature. To this mixture was added 4 38 g (0.026 mol) of 3,4- dichloromaleimide and this mixture was stirred for 4 hours. The reaction mixture was poured into water and filtered. The title compound was recovered in a yield of 3 g (52 percent of theoretical) as a red solid melting at 232-234°C. U C NMR (CDCI ) δ 129.62, 146.03, 165.31 ; MS (El) m/e 243 (M * ), 200. 172, 88. EXAMPLE II: 6-Methyl-5H-Pyrrolo(3',4':5.6)(1 ,4)dιthιιno-(2,3-C)(1 ,2,5)thιadιazole-5.7(6H)-dιone Following the procedure outlined in Example I, the title compound was prepared as an orange-red solid melting at 172-173°C. in a yield of 4.44 g (54 percent of theoretical) by the reaction of 3.7 g (0.024 mol) of 3,4-dιchloro-1 ,2,5-thιadιazole with 1 1.6 g (0.048 mol) of sodium sulfide followed by the addition of 4.38 g (0.026 mol) of 3,4-dιchloro-N-methylmaleιmιde and the reaction thereof. H NMR (CDCI 3 ) δ 3.06 (s, 3H); , 3 C NMR (CDCI ) δ 24 95, 130.05, 146.49, 164.26; MS (El) m/e 257 (M ~ ). 200. 172, 88. EXAMPLE III' 6-Ethyl-5H-Pyrrolo(3',4'.5,6)(1 ,4)dιthιιno-(2,3-C)(1 ,2,5)thιadιazole-5,7(6H)-dιone Following the procedure outlined in Example I, the title compound was prepared as an orange-red solid melting at 114-116°C. in a yield of 5.3 g (62 percent of theoretical) by the reaction of 5.0 g (0.032 mol) of 3,4-dιchloro-1 ,2,5-thιadιazole with 17.0 g (0.07 mol) of sodium sulfide followed by the addition of 6.26 g (0.032 mol) of 20 3,4-dιchloro-N-ethylmaieιmιde and the reaction thereof. Η NMR (CDCI 3 ) δ 122 (t, 3H, J=7.1 Hz), 3.65 (q, 2H, J=7.1 Hz); ' 3 C NMR (CDCI 3 ) δ 13.90, 34.09, 129.82, 146.45, 163.95; MS (El) m/e 271 (M * ), 256, 243, 200, 172, 88. EXAMPLE IV: 6-n-Propyl-5H-Pyrrolo(3',4':5,6)(1 ,4)dιthιιno-(2,3-C)(1 ,2,5)thιadιazole-5,7(6H)-dιone Following the procedure outlined in Example I, the title compound was 5 prepared as an orange-red solid melting at 83-84 c C. in a yield of 4.07 g (55 percent of theoretical) by the reaction of 5.0 g (0.032 mol) of 3,4-dιchloro-1 ,2,5-thιadιazole with 17.03 g (0.071 mol) of sodium sulfide followed by the addition of 6.0 g (0.033 mol) of 3,4-dιchloro-N-n-propylmaleιmιde and the reaction thereof. 'H NMR (CDCIJ δ 0.91 (t, 3H, J=7.4 Hz), 1.63 (m, 2H), 3.50 (t, 2H, J=7.1 Hz); ' C NMR (CDCIJ δ 1 1 23, 21.89, I 0 40.67, 138.75, 146 46, 164.18, MS (El) m/e 285 (M " ), 256. 243, 200. 172, 88. EXAMPLE V 6-n-Hexyl-5H-Pyrrolo(3',4':5,6)(1 ,4)dιthιιno-(2,3-C)(1 ,2,5)thιadιazole-5,7(6H)-dιone Following the procedure outlined in Example I, the title compound was 15 prepared as an orange-red solid melting at 82-83°C. in a yield of 5.85 g (56 percent of theoretical) by the reaction of 5.0 g (0.032 mol) of 3,4-dιchloro-1 ,2,5-thιadιazole with 17.0 g (0.07 mol) of sodium sulfide followed by the addition of 8.07 g (0.032 mol) of 3.4-dιchloro-N-n-hexylmaleιmιde and the reaction thereof. 'H NMR (CDCI.) δ 0.87 (m, 3H), 1.27 (bs, 6H), 1.57 (m, 2H), 3.52 (t, 2H, J=7.1 Hz); '3 C NMR (CDCI 3 ) δ 14.20, 0 22.66, 26.48, 28.55, 31.39, 39.29, 129.89, 146.63, 164.28; MS (El) m/e 327 (M " ), 270, 256, 243, 200, 172, 88. EXAMPLE VI: 6-Phenyl-5H-Pyrrolo(3',4':5,6)(1 ,4)dithιιno-(2,3-C)(1 ,2,5)thιadιazole-5.7(6H)- dione Following the procedure outlined in Example I, the title compound was prepared as a brown solid melting at 223-225°C. in a yield of 3.25 g (85 percent of theoretical) by the reaction of 2.0 g (0.012 mol) of 3,4-dιchloro-1 ,2,5-thιadιazole with 1.93 g (0.025 mol) of sodium sulfide followed by the addition of 3.0 g (0.012 mol) of 3,4-dichloro-N-phenylmaleιmιde and the reaction thereof. I3 C NMR (CDCI.) δ 126.39, 128.16, 128.88. 129.63, 130.72, 145.91 , 163.10; MS (E!) m/e 319 (M " ), 275, 190, 172. EXAMPLE VII: 6-(2-Phenethyl)-5H-Pyrrolo(3',4':5,6)(1 ,4)dιthιιno-(2,3-C)(1 ,2.5)thιadιazole-5,7(6H)- dione Following the procedure outlined in Example I, the title compound was prepared as an orange-red solid melting at 176-178°C in a yield of 6.67 g (60 percent of theoretical) by the reaction of 3.7 g (0.024 mol) of 3,4-dιchloro-1 ,2,5-thιadιazole with 1.6 g (0.048 mol) of sodium sulfide followed by the addition of 4.38 g (0.026 mol) of 3,4-dichloro-N-(2-phenethyl)maleιmιde and the reaction thereof. 'H (CDCI 3 ) δ 2.92 (t, 2H, J=7.9 Hz), 3.79 (t, 2H, J=7.9 Hz), 7.27 (m, 5H); J C NMR (CDCI.) δ 34.56, 40.38, 126.95, 128.73, 129.94, 137.24, 146.54, 164.03; MS (El) m/e 374 (M * ), 256, 243, 200, 91. The compounds of this invention are useful as antimicrobial additives, and they can be added to industrial products such as paints, inks, adhesives, soaps, cutting oils, textiles, and paper and pigment slurries and to styrene-butadiene latexes used for paper coatings. The compounds are also useful as antimicrobial additives in such personal care products as hand creams, lotions, shampoos, and hand soaps. A further advantage of this invention is its cost-effectiveness for applications which need to have an antimicrobial continuously replenished, such as in cooling towers and pulp and paper mills. As appreciated in the art, not all of the compounds disclosed herein are active at the same concentrations or against the same microbial species. That is, there is some compound-to-compound variation in antimicrobial potency and spectrum of antimicrobial activity The present invention is also directed to a method for inhibiting microorganisms which comprises contacting said microorganisms or habitat thereof with an effective amount of the compounds of this invention. The antimicrobial compounds of this invention may be added directly to aqueous formulations susceptible to microbial growth, either undiluted or dissolved in inert diluents such as organic solvents such as glycols, alcohols, or acetone. They may also be added alone or in combination with other preservatives. As used herein, the term "microorganism" is meant to refer to bacteria, fungi, viruses, algae, subviral agents and protozoa. As used herein, the term "antimicrobially-effective amount" refers to that amount of one or a mixture of two or more of the compounds, or of a composition comprising such compound or compounds, of this invention needed to exhibit inhibition of selected microorganisms Typically, this amount varies from providing 1 part per million (ppm) to 5.000 ppm by weight of the compound to a microbial habitat being contacted with the compound Such amounts vary depending upon the particular compound tested and microorganism treated Also, the exact concentration of the compounds to be added in the treatment of industrial and consumer formulations may vary within a product type depending upon the components of the formulation. A preferred effective amount of the compound is from 1 ppm to 500 ppm, more preferably from 1 ppm to 50 ppm by weight, of a microbial habitat. The term "microbial habitat" refers to a place or type of site where a microorganism naturally or normally lives or grows. Typically, such a microbial habitat will be an area that comprises a moisture, nutrient, and/or an oxygen source such as, for example, a cooling water tower or an air washing system. The terms "inhibition", "inhibit" or "inhibiting" refer to the suppression, stasis, kill, or any other interference with the normal life processes of microorganisms that is adverse to such microorganisms, so as to destroy or irreversibly inactivate existing microorganisms and/or prevent or control their future growth and reproduction. The antimicrobial activity of the compounds of the present invention is demonstrated by the following techniques. The antimicrobial activity of the compounds of the present invention is set forth as the minimum inhibitory concentration (MIC) for the active compounds and is determined for nine (9) bacteria, using nutrient agar, and seven (7) yeast and fungi, using malt yeast agar. This determination is conducted using a one percent solution of the test compound prepared in a mixture of acetone and water Nutrient agar is prepared at pH 6.8, representing a neutral medium, and at pH 8.2, representing an alkaline medium. The nutrient agars are prepared by adding 23 g of nutrient agar to one liter of deionized water In addition, the alkaline medium is prepared by adjusting a 0 04 M solution of N-[trιs-(hydroxymethyl)methyl]-glycιne buffered deionized water with concentrated sodium hydroxide to a pH of 8 5 Malt yeast agar is prepared by adding 3 g yeast extract and 45 g malt agar per liter of deionized water The specific agar is dispensed in 30 mL aliquots into 25 x 200 mm test tubes, capped and autoclaved for 15 minutes at 115°C. The test tubes containing the agar are cooled in a water bath until the temperature of the agar is 48°C Then, an appropriate amount of the one percent solution of the test compound is added (except in the controls where no compound is added) to the respective test tubes so that the final concentrations are 500, 250, 100, 50, 25, 10, 5, 2.5, 1 0 and zero parts per million of the test compound in the agar, thus having a known concentration of test compound dispersed therein. The contents of the test tubes are then transferred to respective petri plates. After drying for 24 hours, the petπ plates containing nutrient agar are inoculated with bacteria and those containing malt yeast agar are inoculated with yeast and fungi. The inoculation with bacteria is accomplished by using the following procedure. Twenty-four hour-cultures of each of the bacteria are prepared by incubating the respective bacteria in tubes containing nutrient broth for 24 hours at 30°C in a shaker. Dilutions of each of the 24 hour-cultures are made so that nine separate suspensions (one for each of the nine test bacteria) are made, each containing 10 3 colony forming units (CFU) per mL of suspension of a particular bactena. Aliquots of 0.3 mL of each of the bacterial suspensions are used to fill the individual wells of Steer's Replicator. For each microbial suspension, 0.3 mL was used to fill three wells (that is, three wells of 0.3 mL each) so that for the nine different bacteria, 27 wells are filled. The Steer ' s Replicator is then used to inoculate both the t-eutral and alkaline pH nutrient agar petri plates. The inoculated petri plates are incubated at 30°C for 48 hours and then read to determine if the test compound which is incorporated into the agar prevented growth of the respective bacteria. The inoculation with the yeast and fungi is accomplished as follows. Cultures of yeast and fungi are incubated for seven days on malt yeast agar at 30°C. These cultures are used to prepare suspensions by the following procedure. A suspension of each organism is prepared by adding 10 mL of sterile saline and 10 microliters of octylphenoxy polyethoxy ethanol to the agar slant of yeast or fungi. The sterile saline/octylphenoxy polyethoxy ethanol solution is then agitated with a sterile swab to suspend the microorganism grown on the slant. Each resulting suspension is diluted into sterile saline (1 part suspension to 9 parts sterile saline). Aliquots of these dilutions are placed in individual wells of Steer ' s Replicator and petri plates inoculated as previously described. The petri plates are incubated at 30°C and read after 48 hours for yeast and 72 hours for fungi. Table I lists the bacteria, yeast and fungi used in the MIC test described above along with their respective American Type Culture Collection (ATCC) identification numbers. TABLE I Organisms used in the Minimum Inhibitory Concentration Test Organism ATCC No. Bacteria Bacillus subti s (Bs) 8473 Enterobacter aerogenes (Ea) 13048 Escheπchia coli (Ec) 1 1229 Klebsiella pneumoniae (Kp) 8308 Proteus vulgaπs (Pv) 881 Pseudomonas aeruginosa (Pa) 10145 Pseudomonas aeruginosa (PRD-10) 15442 Salmonella choleraesuis (Sc) 10708 Staphylococcus aureus (Sa) 6538 Yeast/Fungi Aspergillus niger (An) 16404 Candida albicans (Ca) 10231 Penicillium chrysogenum (Pc) 9480 Saccharomyces cerevisiae (Sc) 4105 Tπchoderma viπde (Tv) 8678 Aureobasidium pullulan (Ap) 16622 Fusanum oxysporum (Fo) 481 12 In Tables II and III, the MIC values of the compounds of the present invention as compared to the MIC of a standard commercial preservative (with 1 -(3-chloroallyl)-3,5,7-tπaza-1-azonιaadamantane chloride as the active agent, and referred to in Tables II and III as "STANDARD") are set forth for the bacteria organisms and yeast/fungi organisms which are listed in Table I. TABLE II Minimum Inhibitory Concentrations for Test Compounds in Bacteria Species (in ppm) Compound ORGANISMS (Example No.) Bs Ea Ec Kp Pv PRD Pa Sc Sa STANDARD pH6.8 <10 100 50 25 50 >500 >500 50 25 pH8.2 250 500 >500 500 500 >500 >500 >500 500 (1) pH 6.8 <10 250 100 100 50 500 500 100 100 pH8.2 >500 >500 >500 >500 >500 >500 >500 >500 >500 (II) pH6.8 <10 >500 50 250 25 >500 >500 100 50 pH8.2 250 >500 >500 >500 >500 >500 >500 >500 250 (III) pH6.8 25 >500 50 500 50 >500 >500 250 50 pH8.2 100 >500 >500 >500 >500 >500 >500 >500 250 (IV) pH 6.8 <10 >500 >500 >500 250 >500 >500 500 50 pH8.2 250 >500 >500 >500 >500 >500 >500 >500 50 (V) pH 6.8 <10 >500 >500 >500 >500 >500 >500 >500 <10 pH8.2 25 >500 >500 >500 >500 >500 >500 >500 <10 (VI) pH 6.8 <10 >500 >500 >500 >500 >500 >500 >500 25 pH8.2 100 >500 >500 >500 >500 >500 >500 >500 50 (VII) pH 6.8 >500 >500 >500 >500 >500 >500 >500 >500 >500 pH8.2 >500 >500 >500 >500 >500 >500 >500 >500 >500 TABLE III Minimum Inhibitory Concentrations for Test Compounds in Yeast/Fungi Species (in ppm) Compound ORGANISMS (Example No ) An Ca Pc Sc Tv Ap Fo STANDARD >500 >500 >500 500 >500 >500 >500 1 <1 5 <1 <1 5 <1 <1 II <1 <1 <1 <1 <1 <1 <1 III 25 <10 25 <10 500 <10 250 IV <1 <1 <1 <1 <1 <1 <1 V 25 25 25 25 50 25 25 VI <10 250 <10 100 500 <10 250 VII 100 >500 >500 250 >500 100 >500 The present invention is also directed to a method for inhibiting marine organisms. The term "marine organisms" is meant to include marine animals, such as barnacles, serpulid, bryozoa, oysters and hydroids, and marine plants, such as green algae and brown algae. The method for inhibiting marine organisms comprises contacting a surface exposed to a marine environment in which marine organisms grow with a marine antifouhng effective amount of the compound of this invention. As appreciated by those skilled in the art, not all of the compounds disclosed herein are active at the same concentrations or against the same marine organism species. That is, there may be some compound-to-compound variation in marine antifouhng potency and spectrum of marine antifou ng activity. Furthermore, the level of a specific compound ' s marine antifouhng activity may be dependent on various factors including the specific materials with which the compound is formulated. As used herein, the term "marine antifouhng effective amount" refers to that amount of one or a mixture of two or more of the compounds of this invention needed to exhibit inhibition of selected marine organisms Typically, this amount varies from providing 1 weight percent to 30 weight percent of the compound to a marine antifouling composition which is used to treat a surface exposed to a marine environment in which marine organisms live or grow Such amounts vary depending upon the particular compound tested and marine organism to be treated. Also, the exact concentration of the compounds to be added in the preparation of industrial and consumer formulations may vary within a product type depending upon the components of the formulation. A composition comprising a marine antifouling effective amount of the compound will also comprise an inert diluent which may be, for example, in the form of a paint. Particularly preferred are those paints having a vinyl resin binder such as, for example, a plasticized polyvmyl chloride or a polyvinyl chloride-polyvinyl acetate type. 5 Preferably, the binders are formulated as latexes or emulsions. In a paint composition, the compound of the present invention is preferably used in an amount from 1 to 30 weight percent and, most preferably, from 10 to 25 weight percent. In addition to vinyl resin binder paints, epoxy and poiyurethane binder paints containing the compound may also be useful. Coatings and films prepared from paints comprising the )0 compound of the present invention typically remain substantially free from build-up of marine organisms for periods ranging from 3 to 12 months, depending upon the concentration of the compound and the thickness of the applied coating or film. The term "a surface exposed to a marine environment" refers to a surface where a marine organism naturally or normally lives or grows. Typically, such 15 a surface will be an area that is in continual or periodic contact with a marine environment such as an ocean or other body of water. Typical surfaces include, for example, a ship hull. The marine antifouling activity of the compounds of the present invention is demonstrated by the following techniques. 20 Test panels are prepared from clear, rigid polyvinyl chloride film that is 0.381 x 10 3 m thick and has one textured surface. The test panels are 0.1524 m by 0.1524 m squares that have 0.00635 m holes punched at corners on 0.127 m centers. A 0.102 square template, with a 0.067 m diameter hole at the center, is attached to the center of the textured surface of the test panels. 5 A candidate marine antifoulant compound (1.0 g) is stirred into a resinous latex binder (9.0 g). A portion of the compound/binder mixture (1.5 g) is added to the center of the test panel and uniformly spread over the circular area inside the template. Water is added dropwise as needed to properly spread the 0 compound/binder mixture. The template prevents the compound/binder mixture from spreading beyond the uncovered area. The test panel is allowed to sit for between 10 to 30 minutes until the edge of the spread compound/binder mixture has dried. The template is then removed. The test panel is then allowed to dry for 8 to 12 hours at room temperature. Two test panels are prepared for each candidate manne antifoulant compound. Two control test panels are also prepared by only treating with the resinous latex binder. One test panel of each candidate marine surfactant compound is attached over a white background to the topside of an exposure support apparatus. The second test panel is attached over a black background to the underside of the exposure support apparatus. The exposure support apparatus is placed horizontally 0.0254 m under a marine surface with the white background topside facing up. The exposure support apparatus is exposed to the marine environment for both 6 and 10 weeks during which time the control test panels become substantially covered with mature marine organism growth on both the topside and underside exposures. After being removed from the exposure support apparatus, each test panel is inspected and rated for marine organism growth on both the treated and untreated areas of the test panel. The marine organisms present on the treated and untreated areas are noted. The presence of algae spores and bacterial slime are noted but not included in rating each test panel. The test panels are rated on a scale from 10 (representing completely free of marine organism growth) to 0 (representing completely covered with marine organism growth). In Table IV, the marine antifouhng rating values for some of the active compounds of the present invention are set forth, as well as the ratings for control panels (with no marine antifouling compound and referred to as "Control"). TABLE IV Marine Antifouling Rating for Test Compounds Marine Antifouhng Ratings Test Compound Top Panel at indicated Bottom Panel at time in weeks indicated time in weeks 6 10 16 6 10 16 5H-Pyrrolo(3\4':5,6)- 10 7 8 10 9 9 (1 ,4)dithiιno-(2,3-C)- (1 ,2,5) thiadιazole-5,7-(6H)- dione 6-/ Propyl-5H-Pyrrolo- 9 7 7 9 7 7 (3',4 , :5,6)(1 ,4)-dιthiino-(2,3- C)(1 ,2,5)- thiadiazole-5,7(6H)- dione Control 6 3 - 0 0 -

Claims: 1. A 5H-pyrrolo(3\4':5,6)(1 ,4)dithiino-(2,3-C)-(1 ,2,5)thiadiazole-5,7(6H)- dione corresponding to the formula wherein R represents -H, benzyl, phenethyl, a C,-C 10 straight or branched chain alkyl radical, a C 3 -C 10 cycloalkyl radical, a C t -C 10 straight or branched chain alkoxy radical, a C 3 -C 10 -cycloalkoxy, an ester of the formula -CH 2 CH 2 O-C(O)-R\ wherein R' represents a C,-C 6 straight or branched chain alkyl radical or a C 3 -C 6 cycloalkyl radical or R represents phenyl substituted with from 0-5 halo, C,-C 6 straight or branched chain alkyl, cyano, nitro groups, or an ester of the formula -OC(O)-R', wherein R 1 represents a C.-C 6 straight or branched chain alkyl radical or a C 3 -C 6 cycloalkyl radical or an amide of the formula -C(O)-N(R J ' ι> wherein each R 2 independently represents a C ( -C. straight or branched chain alkyl radical or a C 3 -C 6 cycloalkyl radical. 2. The compound as defined in Claim 1 which is 5H- pyrrolo(3',4 , :5,6)(1 ,4)dithiino(2,3-C)(1 ,2,5)-thiadiazole-5,7(6H)-dione. 3. The compound as defined in Claim 1 which is 6-methyl-5H- pyrrolo(3 , ,4':5,6)(1 ,4)dithiino(2,3-C)-(1 ,2,5)thiadiazole-5,7(6H)-dione. 4. The compound as defined in Claim 1 which is 6-ethyl-5H- pyrrolo(3',4':5,6)(1 ,4)dithiino-(2,3-C)(1 ,2,5)thiadiazole-5,7(6H)-dione. 5. The compound as defined in Claim 1 which is 6-n-propyl-5H- pyrrolo(3',4':5,6)(1 ,4)dithiino-(2,3-C)(1 ,2,5)thiadiazole-5,7(6H)-dione. 6. The compound as defined in Claim 1 which is 6-n-hexyl-5H- pyrrolo(3',4':5,6)(1 ,4)dithiino-(2,3-C)(1 ,2,5)thiadiazole-5,7(6H)-dione. 7. The compound as defined in Claim 1 which is 6-phenyl-5H- pyrrolo(3',4 , :5,6)(1 ,4)dithiino-(2,3-C)(1 ,2,5)thiadiazole-5,7(6H)-dione. 8. The compound as defined in Claim 1 which is 6-(2-phenethyl)-5H- pyrrolo(3',4':5,6)(1 ,4)dithiino-(2,3-C)(1 ,2,5)thiadiazole-5,7(6H)-dione. 9. An antimicrobial composition comprising an inert diluent and an antimicrobiaily-effective amount of a 5H-pyrrolo(3',4':5,6)(1 ,4)dithiino(2,3-C)(1 ,2,5)- thiadiazole-5,7(6H)-dione corresponding to the formula wherein R represents -H, benzyl, phenethyl, a C,-C, 0 straight or branched chain alkyl radical, a C 3 -C 10 cycloalkyl radical, a C.-C 10 straight or branched chain alkoxy radical, a C 3 -C 10 -cycloalkoxy, an ester of the formula -CH 2 CH 2 O-C(O)-R', wherein R 1 represents a O,-C 6 straight or branched chain alkyl radical or a C 3 -C 6 cycloalkyl radical or R represents phenyl substituted with from 0-5 halo, C,-C 6 straight or branched chain alkyl, cyano, nitro groups, or an ester of the formula -OC(O)-R', wherein R' represents a C--C 6 straight or branched chain alkyl radical or a C 3 -C 6 cycloalkyl radical or an amide of the formula -C(O)-N(R 2, κ wherein each R z independently represents a C,-C 6 straight or branched chain alkyl radical or a C 3 -C 6 cycloalkyl radical. 10. The composition as defined in Claim 9 wherein the compound is 5H-pyrrolo(3',4':5,6)(1 ,4)-dithiino(2,3-C)(1 ,2,5)thiadiazole-5,7(6H)-dione. 1 1. The composition as defined in Claim 9 wherein the compound is 6- methyl-5H-pyrrolo-(3',4':5,6)(1 ,4)dithiino(2,3-C)(1 ,2,5)thiadiazole-5,7(6H)-dione. 12. The composition as defined in Claim 9 wherein the compound is 6- ethyl-5H-pyrrolo-(3',4':5,6)(1 ,4)dithiino(2,3-C)(1 ,2,5)thiadiazole-5,7(6H)-dione. 13. The composition as defined in Claim 9 wherein the compound is 6- π-propyl-5H-pyrrolo-(3',4':5,6)(1 ,4)dithiino(2,3-C)(1 ,2,5)thiadiazole-5,7(6H)-dione. 14. The composition as defined in Claim 9 wherein the compound is 6- π-hexyl-5H-pyrrolo-(3',4':5,6)(1 ,4)dithiino(2,3-C)(1 ,2,5)-thiadiazole-5,7(6H)-dione. 15. The composition as defined in Claim 9 wherein the compound is 6- phenyl-5H-pyrrolo-(3',4 , :5,6)(1 l 4)dithiino(2,3-C)(1 ,2,5)-thiadiazole-5,7(6H)-dione. 16. The composition as defined in Claim 9 wherein the compound is 6- (2-phenethyl)-5H-pyrrolo-(3 , ,4 , :5,6)(1 ,4)dithiino(2,3-C)(1 ,2,5)-thiadiazole-5,7(6H)-dione. 17. A method for inhibiting microorganisms in a microbial habitat comprising contacting said microbial habitat with an antimicrobially-effective amount of a 5H-pyrrolo(3',4':5,6)(1 ,4)dithiino(2,3-C)(1 ,2,5)-thiadiazole-5,7(6H)-dione corresponding to the formula wherein R represents -H, benzyl, phenethyl, a C.-C )0 straight or branched chain alkyl radical, a C 3 -C )0 cycloalkyl radical, a C.-C l0 straight or branched chain alkoxy radical, a C 3 -C, 0 -cycloalkoxy, an ester of the formula -CH 2 CH 2 O-C(O)-R', wherein R' represents a C . J -C.. straight or branched chain alkyl radical or a C 3 -C 6 cycloalkyl radical or R represents phenyl substituted with from 0-5 halo, C--C β straight or branched chain alkyl, cyano, nitro groups, or an ester of the formula -OC(O)-R', wherein R' represents a C,-C 6 straight or branched chain alkyl radical or a C 3 -C 6 cycloalkyl radical or an amide of the formula -C(O)-N(R 2 ' ι wherein each R 2 independently represents a C--C 6 straight or branched chain alkyl radical or a C 3 -C 6 cycloalkyl radical. 18. The method composition as defined in Claim 17 wherein the compound is 5H-pyrrolo(3',4':5,6)(1 ,4)-dιthιιno(2,3-C)(1 ,2,5) thιad-azole-5,7(6H)-dιone. 19. The method composition as defined in Claim 17 wherein the compound is 6-methyl-5H-pyrrolo-(3',4':5,6)(1 ,4)dιthιιno(2,3-C)(1 ,2,5)thιadιazole- -5,7(6H)-dιone. 20. The method composition as defined in Claim 17 wherein the compound is 6-ethyl-5H-pyrrolo-(3',4' 5,6)(1 ,4)dιthιιno(2,3-C)(1 ,2,5)thιadιazole-5,7(6H)- dione. 21 The method composition as defined in Claim 17 wherein the compound is 6-n-propyl-5H-pyrrolo-(3',4':5,6)(1 ,4)dιthιιno(2,3-C)(1 ,2,5)thιadιazole- -5,7(6H)-dιone. 22. The method composition as defined in Claim 17 wherein the compound is 6-n-hexyl-5H-pyrrolo-(3',4':5,6)(1 ,4)dιthιιno(2,3-C)(1 ,2,5)- thιadιazole-5,7(6H)-dιone. 23. The method composition as defined in Claim 17 wherein the compound is 6-phenyl-5H-pyrrolo-(3',4':5,6)(1 ,4)dithιιno(2,3-C)(1 ,2,5)thιadιazole- -5,7(6H)-dιone. 24. The method composition as defined in Claim 17 wherein the compound is 6-(2-phenethyl)-5H-pyrrolo-(3',4':5,6)(1 ,4)dιthιιno(2,3-C)(1 ,2,5)thιadιazole- -5,7(6H)-dιone 25. The method of Claim 17 wherein the compound is present in the composition in an amount to provide from 1 part per million to 5,000 parts per million by weight of the compound to the microbial habitat. 26. A composition useful in preventing the growth of marine organisms on a surface exposed to a marine environment in which marine organisms grow comprising an inert diluent and a marine antifou ng effective amount of a 5H- pyrrolo(3',4' 5,6)(1 ,4)-dιthιιno(2,3-C)(1 ,2,5)thιadιazoie-5,7(6H)-dιone corresponding to the formula wherein R represents -H, benzyl, phenethyl, a C -C 10 straight or branched chain alkyl radical, a C 3 -C 10 cycloalkyl radical, a C -C 10 straight or branched chain alkoxy radical, a C 3 -C l0 -cycloalkoxy, an ester of the formula -CH 2 CH 2 O-C(O)-R', wherein R' represents a C.-C 6 straight or branched chain alkyl radical or a C 3 -C β cycloalkyl radical or R represents phenyl substituted with from 0-5 halo, C.-C 6 straight or branched chain alkyl, cyano, nitro groups, or an ester of the formula -OC(O)-R', wherein R' represents a C--C D straight or branched chain alkyl radical or a C 3 -C 6 cycloalkyl radical or an amide of the formula -C(O)-N(R 2) x wherein each R 2 independently represents a C,-C o straight or branched chain alkyl radical or a C 3 -C β cycloalkyl radical 27 A method for preventing the growth of marine organisms on a surface exposed to a marine environment in which marine organisms grow comprising contacting said surface with a marine antifouling effective amount of a 5H- pyrrolo(3',4'-5,6)(1 ,4)-dιthιιno-(2,3-C)(1 ,2,5) thιadιazole-5,7(6H)-dιone corresponding to the formula wherein R represents -H, benzyl, phenethyl, a C.-C, 0 straight or branched chain alkyl radical, a C 3 -C l0 cycloalkyl radical, a C,-C 10 straight or branched chain alkoxy radical, a C 3 -C 0 -cycloalkoxy, an ester of the formula -CH 2 CH 2 O-C(O)-R', wherein R' represents a C -C o straight or branched chain alkyl radical or a C 3 -C β cycloalkyl radical or R represents phenyl substituted with from 0-5 halo, C,-C 6 straight or branched chain alkyl, cyano, nitro groups, or an ester of the formula -OC(O)-R\ wherein R' represents a C,-C 6 straight or branched chain alkyl radical or a C 3 -C. cycloalkyl radical or an amide of the formula -C(O)-N(R , wherein each R 2 independently represents a C,-C 6 straight or branched chain alkyl radical or a C 3 -C 6 cycloalkyl radical. 28. The method of Claim 27 wherein the compound is contacted with the surface in an amount from 1 to 30 weight percent of a composition comprising an inert diluent in admixture with the compound.

Inventors: PEWS R GARTH, ROMER DUANE R, SHANKAR RAVI B, PEWS, R., GARTH, ROMER, DUANE, R., SHANKAR, RAVI, B.
Applicants: DOW CHEMICAL CO, THE DOW CHEMICAL COMPANY
Application year: 1997
Main classification: C07D513
IPC codes: A01N43, C07D513